DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Smaill JB, Palmer BD, Rewcastle GW. et al.
Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.
J Med Chem 1999;
42 (10) 1803-1815
We do not assume any responsibility for the contents of the web pages of other providers.